u/edit_for_clarity

Step therapy requires documented trial of preferred alternatives. It is not an argument to be won on merits; it is a record to be produced, and the record is what the appeal must contain.

Compared two draws across two labs and spent a week worrying before finding out the assays were different.

ask whether the lab changed its assay between your two draws

A series across separate lots estimates a process. Repeat tests on one lot estimate the measurement. Both are useful and they answer different questions.

The confounding problem, stated plainly, because this board keeps stepping on it.

Substantial weight loss moves lipids, liver enzymes, insulin sensitivity markers and several others in its own right. If you are losing weight while taking something, any change in those markers has at least two candidate explanations and you cannot separate them from your own panel.

What you can do is standardise, take a baseline, keep the series long, and be honest in your posts about what is and is not attributable. The threads that say "this compound did X to my ALT" almost never have the design to support the claim, mine included.

Step therapy requires documented trial of preferred alternatives. It is not an argument to be won on merits; it is a record to be produced, and the record is what the appeal must contain.

Right, and weight loss itself moves several markers, so attribution is harder than these threads assume.

Different laboratories use different assay platforms with different calibration. Comparing across labs adds a systematic offset that is invisible on the report.

a peer-to-peer call is often faster than a written appeal

What exactly does the denial letter give as the reason?

peptidemeter_pat is right that the band matters more than the peak.

Adding the boring but useful bit: say whether you paid for it. It is the basis of the whole log.

Some lean mass loss accompanies weight loss in any deficit. Resistance training and adequate protein intake are the two interventions with the best evidence for limiting the proportion.

coming back to say you were wrong takes more than being right did

Same DEXA machine both times?

Push back: your plan is an employer plan, which changes both the appeal path and who the regulator is.

Correcting my own comment: the two draws were 9 weeks apart, not the figure I gave earlier.

Panicked about a single result, posted here, got told to repeat it, repeated it, and it was fine.

Is that the same assay, or did the lab change platforms?

That criterion is from the previous plan year. The current bulletin has different wording.

Push back: three tests on one lot is one lot. It tells you about that lot and almost nothing about the next one.

date of analysis matters as much as the number

That service reports area percent by default. Worth stating, since the thread has been comparing it to a mass figure.

net peptide content if the report gives it, and say which you are quoting

First result I ever posted here got asked for the batch number and the claim. Fair, and my posts have been better ever since.

Batch number and date of analysis?

This. Step therapy is a paperwork requirement and it is beaten with documentation, not persuasion.

Substantial weight loss independently moves lipids, liver enzymes and several other markers. Attributing a change to a compound while losing weight is confounded by design.

What was the claim on the certificate you are comparing against?

draw at the same point in the week if you want comparability

The confounding problem, stated plainly, because this board keeps stepping on it.

Adding the obvious one — take it to whoever ordered the panel. This board cannot read it for you.

Yes.

Disagreeing with this bit: that change is confounded by the weight loss itself and cannot be attributed.

The confounding problem, stated plainly, because this board keeps stepping on it.

Substantial weight loss moves lipids, liver enzymes, insulin sensitivity markers and several others in its own right. If you are losing weight while taking something, any change in those markers has at least two candidate explanations and you cannot separate them from your own panel.

What you can do is standardise, take a baseline, keep the series long, and be honest in your posts about what is and is not attributable. The threads that say "this compound did X to my ApoB" almost never have the design to support the claim, mine included.

Draw at the same point in the week now, fasting, same lab. The noise dropped enormously once I standardised.

Right, and keeping every date and reference number turns a frustrating process into an auditable one.

Careful — the deadline runs from the date on the letter. Waiting for a call back can cost you the appeal entirely.

Yes. Lean mass change during weight loss is expected; the useful question is the proportion, not whether it happens.